# Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/not-ca-25-105-forecast-to-publish-a-notice-of-funding-opportunity/  
Official notice: https://www.grants.gov/search-results-detail/359889

> National Institutes of Health plans to offer grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make about 15 awards. It is a forecast: the notice is expected around December 1, 2025, with applications due around February 18, 2026.

| Field | Value |
|---|---|
| Opportunity number | NOT-CA-25-105 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | expected February 18, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 15 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.398 |

## Who can apply

- State governments
- County governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses

## What the grant funds

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), the Paul Calabresi Career Development Award for Clinical Oncology (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in cancer research. The purpose of the Paul Calabresi Career Development Award for Clinical Oncology, is to increase the number of clinician-scientists trained in clinical and translational cancer research, promote their career development, and prepare them to be effective scientific partners with basic research scientists. NCI Calabresi K12 programs are required to have at least two oncology specialties represented among the included faculty and the pool of K12 appointees (Scholars). The programs are expected to leverage the institution’s unique strengths in these oncology specialties and to incorporate the latest research and technology advancements in designing cutting-edge career development curricula. And the programs must establish individualized career development plans to accommodate Scholars with different levels of prior research training/experience and assign two mentors, a clinician conducting patient-oriented research and a basic science cancer researcher, to each Scholar. The award budgets may include salary support for the PD(s)/PI(s) and Scholars, research and development support, and administrative support costs. The application must clearly indicate the number of Scholar appointments proposed for each year. Candidates must have a full-time appointment at the applicant institution or a partnering institution. Scholar support is provided for a minimum of two years and a maximum of three years of consecutive funding for each scholar, consisting of 12-month appointments, provided their progress towards an independent academic career is on track and satisfactory. The program will allow the appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator as part of their research and career development.

## Questions people ask

### Is NOT-CA-25-105 still open?

Not yet. It is a forecast: expected deadline February 18, 2026.

### Who can apply for Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)?

National Institutes of Health accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

### What is the deadline for Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)?

Expected deadline February 18, 2026. Confirm the date and time in the official notice on Grants.gov.

### Who has won Cancer Research Manpower grants before?

The largest recipients over five fiscal years were Sloan-Kettering Institute for Cancer Research, Dana-Farber Cancer Institute, Inc., The Univeristy of Texas M.D. Anderson Cancer Center. The program made 2,913 awards worth $1.0 billion in that time.